cor2ed
engage checkpoint medical linkedin twitter
bg

TRK fusion-positive cancer: new ESMO OncologyPRO learning resource

TRK fusion-positive cancer: new ESMO OncologyPRO learning resource

Prof. Ezra Cohen, Prof. Frederique Penault-Llorca, Prof. Silvia Stacchiotti, Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, Prof. Christian Rolfo

NTRK CONNECT has developed a comprehensive resource, available at ESMO OncologyPRO, providing information on TRK fusion proteins as a therapeutic target for specific patients across multiple tumour types. The content was first developed in 2019, it has been updated in 2022 to provide the latest information and a greater focus on four tumours: lung cancer, gastrointestinal cancer, thyroid cancer and sarcoma. The content is published on OncologyPRO: The home of ESMO’s educational and scientific resources.

Portrait of Ezra Cohen
Prof. Ezra Cohen

Medical Oncologist

Moores Cancer Center, San Diego

United States (US)

Portrait of Frederique Penault-Llorca
Prof. Frederique Penault-Llorca

Pathologist

University of Clermont-Ferrand

France

Portrait of Silvia Stacchiotti
Prof. Silvia Stacchiotti

Medical Oncologist

Fondazione IRCCS Istituto Nazionale Dei Tumori

Italy

Portrait of Andrea Sartore-Bianchi
Prof. Andrea Sartore-Bianchi

Medical Oncologist

Niguarda Cancer Center

Italy

Portrait of Fernando López-Ríos
Prof. Fernando López-Ríos

Pathologist

Hospital Universitario HM Sanchnarro Universidad CEU San Pablo

Spain

Portrait of Christian Rolfo
Prof. Christian Rolfo

Medical Oncologist

Mount Sinai Hospital

United States (US)

preview next

time OncologyPRO | open 30 min | Sep 2022

temporal

I agree that this educational programme:

TRK Fusion-Positive Cancer

This learning resource has been developed to provide information on the detection and treatment of TRK fusion-positive cancer. The material has been compiled from a review of the medical literature and expert guidance from a scientific committee comprising international experts in the fields of pathology and medical oncology.

There are three modules covering:

  • An overview of cancers with NTRK gene fusions
  • The importance of testing for cancers with NTRK  gene fusions
  • A detailed summary of NTRK gene fusions in selected cancers, namely Lung Cancer, Gastrointestinal Cancer, Thyroid Cancer and Sarcomas

 

NTRK CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.

Other programmes of interest

Other programmes developed by Prof. Ezra Cohen

Other programmes developed by Prof. Frederique Penault-Llorca

Other programmes developed by Prof. Silvia Stacchiotti

Other programmes developed by Prof. Andrea Sartore-Bianchi

Portrait of Andrea Sartore-Bianchi
Prof. Andrea Sartore-Bianchi

Medical Oncologist

Niguarda Cancer Center

Italy

preview next

Other programmes developed by Prof. Fernando López-Ríos

Other programmes developed by Prof. Christian Rolfo